Navigation Links
International Animal/Veterinary Vaccines Market 2013-2018
Date:12/26/2013

DUBLIN, December 26, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/qv4xvl/animalveterinary) has announced the addition of the "International Animal/Veterinary Vaccines Market 2013-2018" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

 

Europe accounts for the largest share of the veterinary vaccines market, followed by North America. Both markets are reaching the maturity phase of growth and will register mid single-digit growth rates for the next five years. Asia, parts of Africa, and LATAM are poised to grow at double-digit rates owing to the increasing investment opportunities for companies in these immature markets and due to the improving healthcare facilities for animals. Countries like China, India, Australia, and Brazil will be major contributors to the growth of the market.

The market is dominated by tier I players and is fairly consolidated with the top 5 players contributing close to 70% of the share. New entrants face high barriers in entering this market as it is a capital-intensive industry with strict regulations.

This research report categorizes the global animal/veterinary vaccines market on the basis of products, animal diseases, and technology. These markets are broken down into segments and sub-segments, providing exhaustive value analysis for 2011, 2012, and 2013 as well as forecasts up to 2018. Each segment of the market is comprehensively analyzed at a granular level, by geography (Europe, North America, Asia, and the Rest of the World), to provide in-depth information on the global scenario.

Key Topics Covered:

1 Introduction
1.1 Key Take-Aways
1.2 Report Description
1.3 Research Methodology
1.4 Markets Covered
1.5 Stakeholders
1.6 Market Scope

2 Executive Summary

3 Market Overview
3.1 Introduction
3.2 Market Segmentation
3.3 Market Dynamics
3.4 Regulations For Animal Vaccines
3.5 Porter's Five Forces Analysis
3.6 Market Share Analysis of Animal Vaccines

4 Global Animal Vaccines Market, By Product
4.1 Introduction
4.2 Companion Animal Vaccines
4.3 Livestock Vaccines
4.4 Poultry Vaccines
4.5 Porcine Vaccines
4.6 Equine Vaccines
4.7 Aquaculture Vaccines
4.8 Other Animal Vaccines

5 Global Animal Vaccines Market, By Disease
5.1 Introduction
5.2 Companion Animal Vaccines
5.3 Livestock Vaccines
5.4 Poultry Vaccines, By Disease
5.5 Porcine Vaccines, By Disease
5.6 Equine Vaccines, By Disease
5.7 Aquaculture Vaccines, By Disease

6 Animal Vaccines Market, By Technology
6.1 Introduction
6.2 Live Attenuated Vaccines (LAV)
6.3 Inactivated Vaccines
6.4 Subunit Vaccines
6.5 Toxoid Vaccines
6.6 Conjugate Vaccines
6.7 Recombinant Vaccines
6.8 Dna Vaccines
6.9 Live Attenuated Technology Contributes The Largest To The Livestock Vaccines Market
6.10 Dna Vaccines Along With Inactivated & Recombinant Technology To Grow At Healthy Pace
6.11 Inactivated Vaccines Technology Accounts For The Largest Share In Porcine Vaccine Market

7 Geographic Analysis
7.1 Introduction
7.2 Europe
7.3 North America
7.4 Asia
7.5 Rest Of The World (ROW)

8 Competitive Landscape
8.1 Introduction
8.2 Mergers & Acquisitions
8.3 Agreements, Partnerships, Collaborations, & Joint Ventures
8.4 New Product Launch
8.5 Other Developments

9 Company Profiles


Companies Mentioned:

  • Bayer Healthcare
  • Biogenesis Bago SA
  • Bioniche Animal Health Canada, Inc
  • Boehringer Ingelheim
  • Ceva (Ceva Sante Animale)
  • Heska Corporation
  • Indian Immunologicals Ltd
  • Lohmann Animal Health International
  • Merck
  • Merial (Animal Health Division Of Sanofi)
  • Novartis Animal Health, Inc
  • Protein Sciences Corporation
  • Virbac
  • Zoetis

For more information visit http://www.researchandmarkets.com/research/qv4xvl/animalveterinary


Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net

 


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
4. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
5. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
6. Chindex International, Inc. to Report First Quarter 2012 Financial Results
7. VWR International, LLC Signs Agreement to Acquire basan Germany GmbH
8. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
9. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
10. Bacterin International Signs Its Third National GPO Contract with Novation
11. SurgLine International, Inc. Chief Executive Officer, Thomas Toland, Exclusive Interview on Stock Traders Talk Radio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... , Feb. 8, 2016  Sangamo BioSciences, ... therapeutic genome editing, announced that the U.S. Food ... Investigational New Drug (IND) application for SB-318, a ... therapy for Mucopolysaccharidosis Type I (MPS I). The ... Sangamo to initiate a Phase 1/2 clinical study ...
(Date:2/8/2016)... February 8, 2016 ... published by Allied Market Research titled, "World ... Forecasts, 2014-2020", estimates the world synthetic biology market ... and sequencing technology segment would continue to lead ... tools segment, collectively, held around half of the ...
(Date:2/8/2016)... HOUSTON , 8. Februar 2016 /PRNewswire/ ... veröffentlichte heute eine Infografik mit dem Titel ... ganzen Welt), mit der der Krankheit gegenüber ... die dazu ermutigen soll, Medikamentenresistenz bei Epilepsie ... der allgemeinen Diskussion zu machen. Mithilfe der ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... 08, 2016 , ... Stephanie Hebert Insurance Agency, serving families ... new charity campaign. As part of their ongoing community involvement program, funds are ... that children deserve a voice, and in the spirit of neighbors helping neighbors ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... expansion into Canada to provide its range of unique and advantaged protective ... Quebec City that will provide bilingual customer service and marketing support. A new ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... announced today that nominations will be accepted February 8, 2016 through May ... , Awards include the Information Security Executive® of the Year, which recognizes ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... lower incidence rate of type 2 diabetes in the GrassrootsHealth cohort with substantially ... to make a change in public health,” states Carole Baggerly, Director of GrassrootsHealth, ...
(Date:2/8/2016)... , ... February 08, 2016 , ... The schedule ... in this country. The AutismOne 2016 Conference, which is being held May 25-29 at ... won’t hear elsewhere about helpful interventions and causes of chronic illness in children. , ...
Breaking Medicine News(10 mins):